Robert L. Myers - 25 Sep 2023 Form 4 Insider Report for Predictive Oncology Inc. (POAI)

Reporting relationship: CHIEF FINANCIAL OFFICER
Issuer ticker: POAI
Reported as of: 25 Sep 2023
Net transaction value: -$1,510
SEC form: 4
Accepted by SEC: 27 Sep 2023, 18:25:18 UTC
Prior SEC filing: 02 Dec 2022
Source filing: View source filing
Reporting owner signature: /s/ Bob Myers

Key filing fact

Robert L. Myers filed Form 4 for Predictive Oncology Inc. (POAI) on 27 Sep 2023.

Key facts

This page summarizes Robert L. Myers's Form 4 filing for Predictive Oncology Inc. (POAI).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 27 Sep 2023, 18:25.

Change

Previous filing in this sequence was filed on 02 Dec 2022.
Current net transaction value: -$1,510.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

POAI transaction

Common Stock

Options Exercise

Transaction value
Shares: +1,667
Change %: +47%
Price
Shares after: 5,230
Date: 25 Sep 2023
Ownership: Direct
Footnotes: F1, F2

POAI transaction

Common Stock

Tax liability

Transaction value: $1,510
Shares: -510
Change %: -9.8%
Price: $2.96
Shares after: 4,720
Date: 25 Sep 2023
Ownership: Direct
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

On September 23, 2020, the Reporting Person was granted 5,000 restricted stock units, vesting in three annual installments on each of September 23, 2021, September 23, 2022 and September 23, 2023.

Footnote F2

Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock. The shares are delivered to the Reporting Person upon vesting.

Footnote F3

510 shares of common stock withheld by the Company on September 25, 2023 to cover withholding tax, in accordance with Restricted Stock Unit Agreement between Reporting Person and Company.